Skip to main content
. Author manuscript; available in PMC: 2021 May 1.
Published in final edited form as: Ann Surg Oncol. 2019 Nov 1;27(5):1659–1670. doi: 10.1245/s10434-019-07982-9

Table 1.

Sociodemographic, disease, and decision-making characteristics for participants (N=143).

Mean (SD) Range N (%) N Missing
Demographic Characteristics
Current Age (years) 45.09 (5.93) 27–54 1
Country of Birth: % United States 118 (82.5) 1
Marital Status: % single 94 (65.7) 1
Education: up to GED/Diploma 120 (83.9) 1
Employment Status: % employed 74 (51.7) 1
Insurance Status: % insured 119 (83.2) 3
Cancer-related Medical Factors
Significant family history: % yes 39 (27.3) 2
Age at Diagnosis (years) 42.87 (6.28) 14–50 1
Cancer Stage at Diagnosis 0
 Localized 81 (56.6)
 Regional 52 (36.4)
 Distant 4 (2.8)
Years from diagnosis to study enrollment 2.38 (3.65) 0.25–37.67 1
Years from genetic testing to follow-up 1.26 (0.27) 0.75–2.50 0
Hormone Receptor Status
 Estrogen Receptor positive: % yes 94 (65.7) 7
 Progesterone Receptor positive: % yes 78 (54.5) 11
 HER2 receptor positive: % yes 25 (17.5) 21
Genetic Testing Result 0
 Carrier 16 (11.2)
 VUS 43 (30.1)
 No mutation 84 (58.7)
Decision-making Factors
Perceived absolute risk of cancer recurrence (%) 22.30 (30.32) 0–100 9
Perceived risk of recurrence relative to other women over age 50 12
 Much lower 47 (32.9)
 A little lower 11 (7.7)
 About the same 40 (28.0)
 A little higher 21 (14.7)
 Much higher 12 (8.4)
HBOC Knowledge 5.06 (2.98) 0–12 1